Skip to main content
SpringerLink
Log in

Use of statins in patients with established idiopathic inflammatory myopathies

  • LETTER TO THE EDITOR
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

A LETTER TO THE EDITOR to this article was published on 21 May 2024

An ORIGINAL ARTICLE to this article was published on 06 November 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fares J, Summer R, Loizidis G (2024) Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013–2023). Clin Rheumatol 43:325–328. https://doi.org/10.1007/s10067-023-06801-7

    Article  PubMed  Google Scholar 

  2. De Moraes MT, De Souza FH, De Barros TB, Shinjo SK (2013) Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease. Arthritis Care Res (Hoboken) 65:793–799

    Article  PubMed  Google Scholar 

  3. Silva MG, Borga EF, Mello SB, Shinjo SK (2016) Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis patients. Clinics (São Paulo) 71:709–714

    Article  PubMed  Google Scholar 

  4. De Souza FH, Shinjo SK (2014) The high prevalence of metabolic syndrome in polymyositis. Clin Exp Rheumatol 32:82–87

    PubMed  Google Scholar 

  5. Araujo PAO, Silva MG, Borba EF, Shinjo SK (2018) High prevalence of metabolic syndrome in antisynthetase syndrome. Clin Exp Rheumatol 36:241–247

    PubMed  Google Scholar 

  6. Borges IBP, Shinjo SK (2019) Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies. Rheumatol Int 39:311–316

    Article  CAS  PubMed  Google Scholar 

  7. Borges IBP, De Oliveira DS, Misse RG, Dos Santos AM, Hong VAC, Bortolloto LA, Shinjo SK (2021) Safety of atorvastatin in patients with stable systemic autoimmune myopathies: a pilot longitudinal study. J Clin Rheumatol 27:S236–S241

    Article  Google Scholar 

  8. Borges IBP, Oba-Shinjo SM, Lerario AM, Marie SKN, Shinjo SK (2024) Effect of atorvastatin on muscle tissues of dermatomyositis and antisynthetase syndrome patients with dyslipidemia. Int J Rheum Dis 27:e14965

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455 – 3 andar, sala 3184, Cerqueira Cesar, Sao Paulo, SP, CEP 01246-903, Brazil

    Samuel Katsuyuki Shinjo

Authors
  1. Samuel Katsuyuki Shinjo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samuel Katsuyuki Shinjo.

Ethics declarations

Disclosures

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shinjo, S.K. Use of statins in patients with established idiopathic inflammatory myopathies. Clin Rheumatol (2024). https://doi.org/10.1007/s10067-024-06977-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10067-024-06977-6

Search

Navigation